Stockreport

Repligen selects Purolite Life Sciences as commercial partner for new high performance ligand [Seeking Alpha]

Repligen Corporation  (RGEN) 
Last repligen corporation earnings: 2/20 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: repligen.com/investors
PDF Repligen selects Purolite Life Sciences as commercial partner for new high performance ligand [Read more]